Soleus Capital Management’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
Other funds holding DXCM
Soleus Capital Management's DXCM Position: Q2 2026 in Review
Soleus Capital Management sold out of DexCom (DXCM) in Q2 2026, closing a stake of 140,000 shares — an estimated $8.79M sold.
Soleus Capital Management first reported a position in DXCM in Q4 2019 and held it in 15 quarters. The position peaked at $86.1M in Q4 2025. 968 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.
- Soleus Capital Management reported no remaining DexCom position as of Q2 2026 after selling out during the quarter.
- Soleus Capital Management sold 140,000 DexCom shares in Q2 2026, an estimated $8.79M.
- Soleus Capital Management first reported a position in DexCom in Q4 2019 and held it in 15 quarters.
- Soleus Capital Management's DexCom position peaked at $86.1M in Q4 2025.
- 968 funds tracked by Wall St. Rank held DexCom as of Q2 2026.
Based on Soleus Capital Management's 13F filing for Q2 2026, filed 11 Aug 2026.